
2,6-Dimethylpiperidine | CAS:504-03-0
2,6-Dimethylpiperidine
- 名称:2,6-二甲基哌啶 | 2,6-Dimethylpiperidine
- CAS号:504-03-0
- 别名:2,6-Lupetidine
- 分子式:C7H15N
- 分子量:113.20
- EINESC号:207-981-6
产品描述
物理化学性质
水溶性 | MISCIBLE |
---|---|
沸点 | 127-128 ºC |
闪点 | 11 ºC |
密度 | 0.84 |
折射率 | 1.4384-1.4404 |
安全数据
危险品标志 | F;C |
---|---|
危险类别码 | R11;R34 |
安全说明书 | S16;S26;S36/37/39 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Density functional theory study of the FT-IR spectra of phthalimide and N-bromophthalimide.V Krishnakumar et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 62(4-5), 918-925 (2005-06-14)
N-bromoimide/DBU combination as a new strategy for intermolecular allylic amination.Ying Wei et al.Organic letters, 15(20), 5186-5189 (2013-10-10)
C2-symmetric cyclic selenium-catalyzed enantioselective bromoaminocyclization.Feng Chen et al.Journal of the American Chemical Society, 135(4), 1232-1235 (2013-01-15)
Titrimetric determination of acetylenic hyponotics using organic brominating agents.A el-Brashy et al.Pharmaceutisch weekblad. Scientific edition, 10(2), 90-92 (1988-04-22)
Titrimetric determination of para-aminobenzoic acid using N-bromophthalimide and N-bromosaccharin.K G Kumar et al.Journal of pharmaceutical and biomedical analysis, 7(5), 627-631 (1989-01-01)
Colorimetric and titrimetric assay of isoniazid.A M el-Brashy et al.Journal of pharmaceutical and biomedical analysis, 10(6), 421-426 (1992-06-01)
Titrimetric methods for the determination of some sulpha drugs using N-bromophthalimide and N-bromosaccharin.K G Kumar et al.The Analyst, 113(9), 1369-1372 (1988-09-01)
Site-selective bromination of vancomycin.Tejas P Pathak et al.Journal of the American Chemical Society, 134(14), 6120-6123 (2012-04-03)
Enantioselective synthesis of multisubstituted biaryl skeleton by chiral phosphoric acid catalyzed desymmetrization/kinetic resolution sequence.Keiji Mori et al.Journal of the American Chemical Society, 135(10), 3964-3970 (2013-02-19)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!